Navigation Links
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
Date:3/18/2013

groups.  The trials are expected to complete in late 2013 or early 2014.  Upon completion of study enrollment and database lock for each trial, and the acceptance of filing of the NDA with the FDA, BDSI is expected to receive milestone payments from Endo totaling $30 million. 
  • BUNAVAIL commercialization opportunities.  BDSI will continue to evaluate its strategic options for the commercialization of BUNAVAIL, which include partnership, internal approaches or a combination of these.  BDSI expects to finalize its strategy in the second half of 2013.
  • Re-introduction of ONSOLIS in the U.S.  In March 2013, BDSI and Meda submitted a proposal to FDA to reintroduce ONSOLIS into the U.S. marketplace following previously reported appearance issues with the product.  If approved by FDA, the original ONSOLIS formulation may be on the market during the second-half of this year while stability data is collected on a newly formulated version of ONSOLIS.  These data may be submitted to FDA before the end of the year, and if approved, could allow introduction of the new formulation sometime in 2014.
  • Exploration of potential new products and technologies.  In addition to advancing its lead products in development, BDSI is also, as in the past, exploring the application of its BEMA drug delivery technology to additional pharmaceuticals.  In addition, BDSI has been investigating potential new products and technologies to complement and diversify its existing portfolio. 
  • About BioDelivery Sciences International
    BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of pro
    '/>"/>

    SOURCE BioDelivery Sciences International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
    2. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
    3. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
    4. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
    5. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
    6. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
    7. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
    8. BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference
    9. BioDelivery Sciences Announces $40 Million Registered Financing
    10. BioDelivery Sciences Announces Completion of BNX Safety Study
    11. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... , Sep. 03, 2015 ... the addition of the "Investigation Report on China ... Oxiracetam, a derivative of pyrrolidone, was first synthesized ... whose oral preparation and injection entered the Italian market ... fast after entering China , annual ...
    (Date:9/2/2015)... About Balloon Kyphoplasty VCF ... more vertebral bodies, resulting in persistent and unbearable ... is a leading cause of VCF among elderly ... tumors, and traumatic injuries also cause VCF. Individuals ... rectify the condition. Both procedures are minimally invasive ...
    (Date:9/2/2015)... LONDON , Sept. 2, 2015 ... Forecasts Summary Advanced dressings have steadily ... treatment of a variety of wound indications, such ... fluid management, infection control, and physical protection become ... a greater role in standard therapy. This ...
    Breaking Medicine Technology:Investigation Report on China's Oxiracetam Market, 2010-2019 2Global Balloon Kyphoplasty Market 2015-2019 2Advanced Wound Dressings - SA Analysis and Market Forecasts 2
    ... Confirm Robust Efficacy of CIMZIA, BOSTON, Nov. ... new,Phase III data from the RAPID 1 and ... Annual Scientific Meeting (ACR), which show,CIMZIA(R) (certolizumab pegol), ... Factor), given with methotrexate, is significantly,more effective than ...
    ... Fla., Nov. 7 A new analysis,presented today ... Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40,mg ... in four,patient populations at varying levels of risk ... subjects defined by the Framingham risk,assessment tool as ...
    Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6
    (Date:9/3/2015)... ... ... Fashion designer Kim (29 years old, Honolulu, HI) designed her own successful transformation ... series “Extreme Weight Loss” Season 5 . Standing just 5’1” and weighing 279 ... motivation to transform when she designed a drop-dead-gorgeous dress and vowed she would do ...
    (Date:9/2/2015)... ... , ... Leah Binder, MA, MGA, president and CEO of ... will offer the keynote address at the upcoming meeting of the ACO and ... Florida, at the Innisbrook Resort and Golf Club. For an agenda and registration, ...
    (Date:9/2/2015)... ... 2015 , ... Sara Bleich, Ph.D., associate professor of health ... an internationally recognized scholar on obesity prevention and control, has been selected for ... and 1996 graduate of Garrison Forest School, an all-girls’ independent school in Owings ...
    (Date:9/2/2015)... CA (PRWEB) , ... September 02, 2015 , ... The ... genome by using a complex of the Cas9 nuclease with either a chimeric single ... RNA (tracrRNA)). The ability of any given guide RNA (sgRNA or crRNA) to create ...
    (Date:9/2/2015)... ... September 02, 2015 , ... ... Warrior-Family Symposium (WFS), cosponsored by the Military Officers Association of America (MOAA) ... event, "Our Nation's Military: Caring For Our Own,” expert panelists will lead ...
    Breaking Medicine News(10 mins):Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3
    ... TRIANGLE PARK, N.C. (April 23, 2009) Talecris ... health-related quality of life results from the largest ... inflammatory demyelinating polyneuropathy (CIDP) in the April 14, ... data demonstrate that long-term treatment with Gamunex (Immune ...
    ... Drug Companies to Adopt "Smart" Drug Safety TechnologyARMONK, N.Y. ... -- IBM (NYSE: IBM ... Golden State Medical Supply (GSMS) today announced the two ... with stringent prescription drug pedigree regulations in advance of ...
    ... MMR Information Systems, Inc. (OTC Bulletin Board: ... Inc. (collectively, "MMR") provides consumer-controlled Personal Health Records ... safe deposit box storage solutions ( www.myesafedepositbox.com ... products for healthcare professionals and investors scheduled for ...
    ... Protect Children From Malaria, Killer of 3,000 African Children ... today announced that it will be the recipient of ... provision of insecticide-treated nets (ITNs) meant to stem the ... April 25.The gift comes as the result of a ...
    ... hit television show Grey,s Anatomy has selected the ... charities and has listed the AAN Foundation on the Grey,s Anatomy online ... Derek "McDreamy" Shepherd. Fans and the public are encouraged to make ... gifts. The public can buy a virtual brain for $5 with ...
    ... United Concordia and the Harrisburg Area Dental Society Team ... for a Healthy Community CAMP HILL, Pa., April 24 ... a day of free health and vision screenings and dental care ... public is invited to participate in this day-long community event which ...
    Cached Medicine News:Health News:Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP 2Health News:Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP 3Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 2Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 3Health News:MMR Announces Webinar to Demonstrate MyMedicalRecords PHR Product Line 2Health News:MMR Announces Webinar to Demonstrate MyMedicalRecords PHR Product Line 3Health News:Children Emerge as Winners in Twitter Challenge Between Ashton Kutcher and CNN 2Health News:Children Emerge as Winners in Twitter Challenge Between Ashton Kutcher and CNN 3Health News:AAN Foundation Benefits from Grey's Anatomy 'Wedding Registry' 2Health News:Free Health, Dental and Vision Screenings at Hamilton Health Center on May 2 Will Help Harrisburg Area Children and Adults 2Health News:Free Health, Dental and Vision Screenings at Hamilton Health Center on May 2 Will Help Harrisburg Area Children and Adults 3Health News:Free Health, Dental and Vision Screenings at Hamilton Health Center on May 2 Will Help Harrisburg Area Children and Adults 4
    ... MCS + 9000 system is Haemonetics' latest ... portfolio of protocols for the collection of ... these. It also offers a range of ... of this system enables blood collection organizations ...
    ... The PCS2 system ... for the collection of ... allow for the collection ... platelet-poor plasma, platelet-poor plasma ...
    The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
    ... Finnpipette Stepper, a lightweight, easy-to-use ... dispensing up to 45 times ... universal Stepper handle is adapted ... cover a dispensing volume range ...
    Medicine Products: